
Shares of Australia's Tetratherix TTX.AX rise as much as 10.1% to A$4.24, their highest level since mid-November
Stock set for its strongest session in six weeks, if current trends hold
Regenerative biomaterials maker says BioOptix, which is co's JV partner has entered agreement with Alcon Research
Under agreement, Alcon Research to provide funding to speed up commercialization of products from Tetramatrix platform technology
Tetramatrix platform technology is a biomaterial platform which creates implantable products for diverse clinical needs - co's website
Stock up near 25% since it listed on June 30